Wearable breast pump (Model: XN/MD-2249BS, ZFHF)
Guangdong Horigen Mother & Baby Products Co., Ltd. · Decision date Sep 1, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 1, 2026 for K262774, a wearable breast pump submitted by Guangdong Horigen Mother & Baby Products Co., Ltd. of Shantou, China. The device is listed under the name Wearable breast pump (Model: XN/MD-2249BS, ZFHF), classified as Pump, Breast, Powered under 21 CFR 884.5160, product code HGX, in the Obstetrics/Gynecology panel. The submission was received August 4, 2026 and reviewed by a third party; it is a traditional 510(k), not a combination product, and no predetermined change control plan was authorized.
The summary describes a non-sterile, integrated wearable device intended for use in a home environment and for single pumping on one breast, with components including a diaphragm, valve, link and a combined milk collector and flange. Clearance means FDA found substantial equivalence to legally marketed predicate devices; it is not premarket approval of a new system. The available excerpts are fragmentary, and the specific predicate device or devices, performance testing results and any clinical data are not identified in the provided material.
The public record does not state whether the listed model designations represent separate configurations or a single device family, and no efficacy or safety conclusions should be drawn from the clearance decision alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262774
- Regulatory pathway
- 510(k) premarket notification
- Product code
- HGX
- Decision code
- SESE
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pump, Breast, Powered.
- Product code
- HGX
- FDA device class
- 2
FDA decision timeline
K262774 received
Application receipt date recorded by FDA.
K262774 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HGX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nenesupply Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Tomy International, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen TPH Technology Co., Ltd. | 510(k) clearance | Sep 17, 2026 | FDA | |
| Philips Consumer Lifestyle B.V. | 510(k) clearance | Sep 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guangdong Horigen Mother & Baby Products Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shantou
Sources and methodology
- Original FDA record: K262774
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

